Company intelligence / Profile preview
Infirst Healthcare
Westport, Connecticut, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Infirst Healthcare markets and commercializes well-known OTC brands such as Mylanta and Mylicon (digestive health), Dr. Cocoa (cough and cold), and medical devices, focusing on established molecules and consumer needs in the US retail market. Clinical-stage development is not indicated in public information, as the business is focused on commercialization of established ingredients through brand and formulation innovation.
- Therapeutic areas
- Infectious DiseasesGastroenterology
- Modalities
- Small moleculeDevice
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
McNeil Consumer Pharmaceuticals Co. (licensing for Mylanta, Mylicon)
Beyond the preview
Go deeper on Infirst Healthcare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Infirst Healthcare.